Website
Now part of the http://www.pharmaxisgroup.com
Pharmaxis is a clinical-stage drug development company with expertise in inflammation and fibrosis across respiratory and rare diseases.
Pharmaxis developed Bronchitol®, an inhaled mannitol therapy for cystic fibrosis and bronchiectasis, approved in multiple countries. The company also has a pipeline of small-molecule drugs targeting LOX and LOXL2 for liver and skin fibrosis.
